Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...

Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action by Policymakers and Regulators Alexandria, Va., July 09, 2024 (GLOBE NEWSWIRE) -- The interim report published today by the Federal Trade Commission – titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs...

Local Pharmacies on the Brink, New Survey Reveals Alexandria, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association today...